Skip to main content
THERAGEN ETEX CO.,LTD. logo

THERAGEN ETEX CO.,LTD. — Investor Relations & Filings

Ticker · 066700 ISIN · KR7066700006 KO Manufacturing
Open in API
Filings indexed 193 across all filing types
Latest filing 2023-03-21 Audit Report / Informat…
Country KR South Korea
Listing KO 066700

About THERAGEN ETEX CO.,LTD.

http://www.theragenetex.com/

THERAGEN ETEX CO.,LTD. is a biotechnology and pharmaceutical group focused on genome-based personalized and precision medicine. The company integrates advanced genomic analysis with pharmaceutical development and manufacturing. Its genomics division provides comprehensive genetic analysis services, leveraging pioneering achievements such as creating the world's first female and tiger genome maps and commercializing Asia's first individual genome analysis service. The pharmaceutical division develops and supplies medicines from its international GMP-certified facilities. The R&D pipeline focuses on incrementally modified drugs, orphan drugs, and novel anticancer therapies, including its proprietary drug candidate, Vactosertib, which is in clinical trials for various cancers.

Recent filings

Filing Released Lang Actions
감사보고서제출
Audit Report / Information Classification · 100% confidence The document is a formal regulatory filing titled '감사보고서 제출' (Submission of Audit Report) submitted to the Korea Exchange (KRX). It provides key financial data, audit opinions, and financial statements for the fiscal year. While it contains financial information, it is a structured regulatory disclosure announcement rather than the full, multi-page annual report document itself. According to the 'Menu vs Meal' rule, this is a regulatory filing announcement, and since it does not fit into other specific categories like Earnings Release or Annual Report, it is classified as a Regulatory Filing (RNS). FY 2022
2023-03-21 Korean
사업보고서 (2022.12)
Annual Report Classification · 100% confidence The document is a 'Business Report' (사업보고서) for the fiscal year 2022 (Jan 1, 2022 - Dec 31, 2022) submitted to the Financial Supervisory Service and Korea Exchange. It contains comprehensive financial data, business overviews, management discussions, and corporate governance details. In the context of Korean regulatory filings, the 'Business Report' (사업보고서) is the equivalent of the US 10-K annual report. It is not an announcement or a summary, but the full annual report itself. FY 2022
2023-03-21 Korean
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a 'Notice of General Meeting of Shareholders' (주주총회소집공고) for (주)테라젠이텍스. It contains the agenda for the 33rd Annual General Meeting, including items such as the approval of financial statements, election of directors, and remuneration limits. This document is a formal proxy solicitation and information statement provided to shareholders to inform them of the meeting and request their votes, which aligns with the definition of a Proxy Solicitation & Information Statement (PSI).
2023-03-10 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is titled '의결권대리행사권유참고서류' (Proxy Solicitation Reference Document) and contains detailed information regarding the upcoming Annual General Meeting (AGM), including the purpose of the meeting, voting procedures (electronic voting/proxy), and the agenda items. This document is a standard proxy solicitation material sent to shareholders to request their votes for the meeting, which falls under the 'Proxy Solicitation & Information Statement' category.
2023-03-10 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release Classification · 100% confidence The document is a regulatory filing from the Korea Exchange (KRX) system regarding a significant change in revenue or profit structure (30% or more). This is a standard periodic financial disclosure required by Korean regulations when financial results deviate significantly from the previous period. It provides key financial highlights (revenue, operating profit, net income) and explanations for the changes. It is not a full annual report (10-K) or an interim report (IR), but rather a specific regulatory disclosure of financial performance highlights, which falls under the Earnings Release (ER) category in this taxonomy. FY 2022
2023-03-07 Korean
주주총회소집결의
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) issued by Teragen Etex. It outlines the date, location, and agenda items for the upcoming Annual General Meeting, including the approval of financial statements, election of directors and auditors, and remuneration limits. This document serves as the official proxy solicitation and information statement provided to shareholders to inform them of the meeting and the matters to be voted upon.
2023-03-07 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.